The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Cox, Susan Elizabeth
    Director born in February 1952
    Individual (1 offspring)
    Officer
    2022-02-22 ~ now
    OF - Director → CIF 0
    Mrs Susan Elizabeth Cox
    Born in February 1952
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Cox, Roger Bertram, Dr
    Director born in March 1950
    Individual (1 offspring)
    Officer
    2008-06-18 ~ now
    OF - Director → CIF 0
    Dr Roger Bertram Cox
    Born in March 1950
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
Ceased 1
  • 19, Moulton Park Office Village, Scirocco Close, Northampton
    Dissolved Corporate (3 parents, 5 offsprings)
    Officer
    2008-06-18 ~ 2008-06-18
    PE - Secretary → CIF 0
parent relation
Company in focus

BIOPHARMPERSPECTIVES LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
1,968 GBP2024-03-31
2,026 GBP2023-03-31
Cash at bank and in hand
119,103 GBP2024-03-31
154,893 GBP2023-03-31
Creditors
Current
9,788 GBP2024-03-31
14,177 GBP2023-03-31
Net Current Assets/Liabilities
109,315 GBP2024-03-31
140,716 GBP2023-03-31
Total Assets Less Current Liabilities
111,283 GBP2024-03-31
142,742 GBP2023-03-31
Equity
Called up share capital
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
111,183 GBP2024-03-31
142,642 GBP2023-03-31
Equity
111,283 GBP2024-03-31
142,742 GBP2023-03-31
Average Number of Employees
12023-04-01 ~ 2024-03-31
12022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
12,546 GBP2024-03-31
11,546 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
10,578 GBP2024-03-31
9,520 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
1,058 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
1,968 GBP2024-03-31
2,026 GBP2023-03-31
Other Taxation & Social Security Payable
Current
6,729 GBP2024-03-31
10,631 GBP2023-03-31
Other Creditors
Current
3,059 GBP2024-03-31
3,546 GBP2023-03-31

  • BIOPHARMPERSPECTIVES LIMITED
    Info
    Registered number 06622997
    4th Floor Tuition House 27-37 St George's Road, Wimbledon, London SW19 4EU
    Private Limited Company incorporated on 2008-06-18 (17 years). The company status is Active.
    The last date of confirmation statement was made at 2024-06-18
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.